B Capital
Healthcare
Pharmeasy eyes $304 mn in funding from Manipal Group, existing investors
Omnichannel pharmacy chain Pharmeasy plans to raise ₹2,500 crore ($304 million) to retire the senior debt it had raised from ......
Healthcare
B Capital, Chiratae, Peak XV-backed D2C startup Mojocare's books under scanner, fires 80% staff
A year after investing $20 million in Series A funding, investors B Capital, Chiratae Ventures, Better Capital, and Peak XV ......
Consumer
B Capital, two other VC firms eyeing investment in nutraceutical startup
US-based venture capital firm B Capital Group, which has backed companies such as Byju’s and Meesho, and two other VC ......
TMT
Where is the SaaS sector headed on M&A street in 2023?
Consolidation in the software-as-a-service (SaaS) sector is likely to moderate in the near-term, industry experts believe, as overall deal volume across ......
TMT
Deals Digest: VC funding dips in value, small deals dominate this week
Investments in venture capital (VC) and private equity (PE) declined 17.8% this week to $236 million from last week’s $287 ......
Finance
Inside B Capital's early stage sectoral focus
B Capital Group expects software-as-a-service (SaaS), healthcare and business-to-business (B2B) platforms to comprise 60% of its investments at the early-stage ......
TMT
FalconX earmarks up to $150 mn for acquisitions globally, eyes acqui-hires in India
Accel-backed FalconX Ltd is looking at acquisitions globally to scale its crypto product offerings while it is planning to make ......
Finance
Weekly Deal Wrap: Mega PE cheques thrust Warburg, Ares SSG into limelight
Private equity accounted for the biggest deals in the second week of March with Ares SSG and Warburg Pincus paying ......
TMT
Icertis CFO on how the PremjiInvest-backed SaaS firm is using investor capital
Over the past five years enterprise contract lifecycle management company Icertis Inc. has raised more than $200 million from investors ......
Finance
Coronavirus knocks angel and seed deals off perch, continues to clobber VC investments
Venture deal volumes, which have suffered since March when the lockdown started, continued to remain subdued last month even as ......
